Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate.

MLA

Nijenhuis, Marga, et al. “Dutch Pharmacogenetics Working Group (DPWG) Guideline for the Gene-Drug Interaction of CYP2D6 and COMT with Atomoxetine and Methylphenidate.” European Journal of Human Genetics : EJHG, vol. 31, no. 12, Dec. 2023, pp. 1364–70. EBSCOhost, https://doi.org/10.1038/s41431-022-01262-z.

APA

Nijenhuis, M., Soree, B., Jama, W. O. M., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H.-J., Houwink, E. J. F., Rongen, G. A., van Schaik, R. H. N., Swen, J. J., Touw, D., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., & Risselada, A. (2023). Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate. European Journal of Human Genetics : EJHG, 31(12), 1364–1370. https://doi.org/10.1038/s41431-022-01262-z

Chicago

Nijenhuis, Marga, Bianca Soree, Wafa O M Jama, Nienke J de Boer-Veger, Anne Marie Buunk, Henk-Jan Guchelaar, Elisa J F Houwink, et al. 2023. “Dutch Pharmacogenetics Working Group (DPWG) Guideline for the Gene-Drug Interaction of CYP2D6 and COMT with Atomoxetine and Methylphenidate.” European Journal of Human Genetics : EJHG 31 (12): 1364–70. doi:10.1038/s41431-022-01262-z.